NGL FINECHEM
Back to Balance Sheet
|
NGL FINECHEM Last 5 Year Short Term Loans and Advances History
[Consolidated]
| Mar2026 | Mar2025 | Mar2024 | Mar2023 | Mar2022 | |
|---|---|---|---|---|---|
| Short Term Loans and Advances | ₹19 Cr | ₹4.69 Cr | ₹21 Cr | ₹15 Cr | ₹21 Cr |
What is the latest Short Term Loans and Advances ratio of NGL FINECHEM ?
| Year | Short Term Loans and Advances |
|---|---|
| Mar2026 | ₹19 Cr |
| Mar2025 | ₹4.69 Cr |
| Mar2024 | ₹21 Cr |
| Mar2023 | ₹15 Cr |
| Mar2022 | ₹21 Cr |
How is Short Term Loans and Advances of NGL FINECHEM Trending?
| Years | Short Term Loans and Advances | % Change | |
|---|---|---|---|
| Mar2026 | ₹19 Cr | 301.77 | |
| Mar2025 | ₹4.69 Cr | -77.75 | |
| Mar2024 | ₹21 Cr | 40.13 | |
| Mar2023 | ₹15 Cr | -28.97 | |
| Mar2022 | ₹21 Cr | - | |
Compare Short Term Loans and Advances of peers of NGL FINECHEM
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| NGL FINECHEM | ₹1,783.3 Cr | 1% | 2.3% | 92.6% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹446,276.0 Cr | -0.3% | -3.1% | 12.8% | Stock Analytics | |
| DIVIS LABORATORIES | ₹251,531.0 Cr | -1.3% | 2.2% | 57.5% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹186,957.0 Cr | -1.3% | -2.4% | 33.3% | Stock Analytics | |
| CIPLA | ₹111,729.0 Cr | 0.2% | -2.5% | -9.1% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹104,335.0 Cr | 3.3% | 6.1% | -6.5% | Stock Analytics | |
NGL FINECHEM Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| NGL FINECHEM | 1% |
2.3% |
92.6% |
| SENSEX | -2.7% |
-5.7% |
-11.7% |
You may also like the below Video Courses